1. Home
  2. IPHA vs OGI Comparison

IPHA vs OGI Comparison

Compare IPHA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
    SELLHOLDBUYas of 16 hours ago
  • OGI
    SELLHOLDBUYas of 16 hours ago
  • Stock Information
  • Founded
  • IPHA 1999
  • OGI 2013
  • Country
  • IPHA France
  • OGI Canada
  • Employees
  • IPHA N/A
  • OGI N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • OGI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPHA Health Care
  • OGI Health Care
  • Exchange
  • IPHA Nasdaq
  • OGI Nasdaq
  • Market Cap
  • IPHA 148.3M
  • OGI 200.6M
  • IPO Year
  • IPHA 2019
  • OGI N/A
  • Fundamental
  • Price
  • IPHA $1.77
  • OGI $1.57
  • Analyst Decision
  • IPHA Strong Buy
  • OGI
  • Analyst Count
  • IPHA 1
  • OGI 0
  • Target Price
  • IPHA $11.50
  • OGI N/A
  • AVG Volume (30 Days)
  • IPHA 42.6K
  • OGI 555.7K
  • Earning Date
  • IPHA 09-12-2024
  • OGI 02-11-2025
  • Dividend Yield
  • IPHA N/A
  • OGI N/A
  • EPS Growth
  • IPHA N/A
  • OGI N/A
  • EPS
  • IPHA N/A
  • OGI N/A
  • Revenue
  • IPHA $36,202,722.00
  • OGI $118,317,480.00
  • Revenue This Year
  • IPHA N/A
  • OGI $57.65
  • Revenue Next Year
  • IPHA $101.65
  • OGI $10.93
  • P/E Ratio
  • IPHA N/A
  • OGI N/A
  • Revenue Growth
  • IPHA N/A
  • OGI 0.69
  • 52 Week Low
  • IPHA $1.29
  • OGI $1.31
  • 52 Week High
  • IPHA $3.51
  • OGI $2.91
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 46.79
  • OGI 49.23
  • Support Level
  • IPHA $1.65
  • OGI $1.51
  • Resistance Level
  • IPHA $1.87
  • OGI $1.60
  • Average True Range (ATR)
  • IPHA 0.11
  • OGI 0.08
  • MACD
  • IPHA -0.02
  • OGI -0.01
  • Stochastic Oscillator
  • IPHA 47.89
  • OGI 25.93

Stock Price Comparison Chart: IPHA vs OGI

IPHA
OGI
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025024681012141618202224IPHA VS OGI

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About OGI Organigram Holdings Inc.

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use